Serum triglycerides were significantly different between patients with steatosis and those with steatohepatitis (p = 0.048), as well as serum insulin levels; however, other metabolic biochemical markers remained without significant change between patients before cholecystectomy and in the 6-month follow-up period (Supplementary Table S2). This evidence concerns the gene INS and steatosis.